Markets:

Overview

News

Currencies

International

Treasuries

Evaxion A/S - American Depositary Share (NQ:EVAX)

4.840 +0.070 (+1.47%)

Streaming Delayed Price Updated: 9:44 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evaxion A/S - American Depositary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 03, 2023

Via Benzinga

Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01

January 03, 2023

From Evaxion Biotech

Via GlobeNewswire

Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...

Via Benzinga

Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023

December 15, 2022

From Evaxion Biotech

Via GlobeNewswire

Evaxion Biotech Highlights Promising Data From Personalized Cancer Immunotherapy ↗

November 17, 2022

Via Benzinga

Recap: Evaxion Biotech Q2 Earnings ↗

August 10, 2022

Evaxion Biotech (NASDAQ:EVAX) reported its Q2 earnings results on Wednesday, August 10, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Evaxion, ExpreS2ion Ink Research Pact For Cytomegalovirus Vaccine Candidate ↗

December 06, 2022

Via Benzinga

Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate

December 06, 2022

From Evaxion Biotech

Via GlobeNewswire

Evaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02

November 17, 2022

From Evaxion Biotech

Via GlobeNewswire

Evaxion Announces Third Quarter 2022 Financial Results and Business Update

November 14, 2022

From Evaxion Biotech

Via GlobeNewswire

Evaxion Biotech To Test EVX-03 DNA Vaccine For Non-Small Cell Lung Cancer ↗

June 23, 2022

Via Benzinga

Evaxion CEO comments on strategic focus

November 10, 2022

From Evaxion Biotech

Via GlobeNewswire

Evaxion welcomes Per Norlén as new CEO.

October 05, 2022

From Evaxion Biotech

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 27, 2022

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 27, 2022

Gainers

Via Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

US Stocks Open Higher; Dow Surges 300 Points ↗

September 27, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday.

Via Benzinga

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday ↗

September 26, 2022

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 22, 2022

Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 22, 2022

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

Via InvestorPlace

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket ↗

September 22, 2022

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem...

Via Benzinga

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗

September 22, 2022

Gainers

Via Benzinga

US Stocks Edge Higher As Fed Raises Interest Rates By 75 Basis Points ↗

September 21, 2022

U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate decision by the Fed.

Via Benzinga

Why Is Evaxion Biotech (EVAX) Stock Up Today? ↗

September 21, 2022

Today's news that Evaxion Biotech has enrolled its first patient in a key clinical trial has sent shares of EVAX stock soaring today.

Via InvestorPlace

Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session ↗

September 21, 2022

Gainers

Via Benzinga

S&P 500 Rises 0.5%; Crude Oil Falls Sharply ↗

September 21, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday.

Via Benzinga

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗

July 27, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session ↗

July 26, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study ↗

June 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.